05:29 , Jun 2, 2018 |  BioCentury  |  Strategy

Partnering on a mission

With a $260 million war chest and a banner roster of execs, advisors and deals, Brii Biosciences is pushing an agenda to bring infectious diseases to the forefront of innovation in China. Its top priority...
17:52 , Jun 1, 2018 |  BC Week In Review  |  Financial News

Chinese investors lead Grail's $300M series C

Cancer detection company Grail Inc. (Menlo Park, Calif.) raised $300 million in an oversubscribed series C round on May 21. Ally Bridge Group, Hillhouse Capital and 6 Dimensions Capital led the round, with participation from...
18:22 , May 25, 2018 |  BC Week In Review  |  Financial News

Chinese newco Brii launches with $260M

Arch Venture Partners and a syndicate of U.S. and Chinese investors launched Brii Biosciences (Shanghai, China) on May 24 with $260 million in committed capital and a series of high-profile partnerships spanning asset acquisition through...
17:40 , May 25, 2018 |  BioCentury  |  Finance

Grail’s Asia incentives

In light of Grail Inc.’s $300 million series C round from Chinese investors, the cancer detection company has several reasons to pursue a Hong Kong listing that go beyond high valuations. The series C round,...
12:24 , May 24, 2018 |  BC Extra  |  Company News

Chinese newco Brii launches with $260M

Arch Venture Partners and a syndicate of U.S. and Chinese investors launched Brii Biosciences (Shanghai, China) on Thursday with $260 million in committed capital and a series of high-profile partnerships spanning asset acquisition through commercialization...
00:12 , May 22, 2018 |  BC Extra  |  Financial News

Chinese investors lead Grail's $300M series C

Cancer detection company Grail Inc. (Menlo Park, Calif.) raised $300 million in an oversubscribed series C round late Monday. The company said the round was led by Ally Bridge Group and co-led by Hillhouse Capital...
19:13 , May 18, 2018 |  BC Week In Review  |  Financial News

Stapled peptide company FOG raises $66M series B

FOG Pharmaceuticals Inc. (Cambridge, Mass.) raised $66 million in a series B round led by 6 Dimensions Capital. New investors GV, Blue Pool Capital, Horizons Ventures, Nan Fung Group and Leerink Partners also participated, as...
12:01 , May 16, 2018 |  BC Extra  |  Financial News

Stapled peptide company FOG raises $66M series B

FOG Pharmaceuticals Inc. (Cambridge, Mass.) raised $66 million in a series B round led by 6 Dimensions Capital. New investors GV, Blue Pool Capital, Horizons Ventures, Nan Fung Group and Leerink Partners also participated, as...
15:17 , Mar 30, 2018 |  BC Week In Review  |  Financial News

Hua raises $117.4M with listing in sight

Hua Medicine Ltd. (Shanghai, China) raised a total of $117.4 million on March 27 in its series D and E rounds. New investors included Blue Pool Capital, GIC Private, AVICT Global, 6 Dimensions Capital, Adrian...
00:20 , Mar 30, 2018 |  BioCentury  |  Finance

Heading for Hong Kong

Raising substantially more than planned in a pair of oversubscribed venture rounds gives Hua Medicine Ltd. more breathing room as the Shanghai diabetes company readies itself to be among the first biotechs to list in...